ArticlePhysiological research2026
Simulated Microgravity Inhibited the Proliferation of Bovine Muscle Satellite Cells.
Article in Physiological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to assess the effects of simulated microgravity (SMG) on bovine muscle satellite cells (bSCs). The results demonstrated that bSCs maintained a fibroblast-like morphology throughout SMG exposure from day 3 to day 7. However, cells in the SMG group exhibited reduced proliferation compared to the control group, as indicated by lower cell density at both time points. In contrast, cell viability was higher in the SMG group than in the control group. Cell cycle analysis revealed a higher proportion of SMG-treated bSCs in the G0/G1 phase and a lower proportion in the S phase at day 3, suggesting cell cycle arrest at an early stage. Interestingly, by day 7, the percentage of cells in the S phase increased in the SMG group and exceeded that of the control group, indicating a partial recovery of proliferative activity. Western blot analysis showed decreased expression of key cell cycle-related proteins, including cyclin A1/A2, cyclin D1, and CDK2, in SMG-treated cells compared to controls at the early stage. Notably, cyclin D1 and CDK2 expression levels were upregulated at the later stage under SMG conditions. Additionally, nuclear morphology in SMG-treated bSCs displayed enlargement and irregularity. Overall, these findings suggest that SMG initially suppresses bSC proliferation by inducing cell cycle arrest, but cells can partially retrieve their proliferative capacity at later stages, potentially through upregulation of cell cycle regulatory proteins.
Indexed as
Identifiers
42708875PMC13580670What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.